Detected ·
Revier Therapeutics
€6M—
Revier Therapeutics launches with €6M in seed financing to develop selective class IIa HDAC inhibitors for cardiometabolic diseases.
- Website
- revier.bio
- Amount
- €6 000 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-26 04:26:22 UTC
- Signal ID
- e50d4b37-c37f-416b-a97e-8b42777de896
As the API returns it
{
"id": "e50d4b37-c37f-416b-a97e-8b42777de896",
"created_at": "2026-08-26T04:26:22.367295Z",
"company_name": "Revier Therapeutics",
"company_website_url": "revier.bio",
"company_linkedin_url": "https://www.linkedin.com/company/revier-therapeutics",
"event_type": "funding",
"funding_amount": 6000000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Revier Therapeutics launches with €6M in seed financing to develop selective class IIa HDAC inhibitors for cardiometabolic diseases.*"
}